Horton MW - Search Results

1

Multiple-dose pharmacokinetics of pentoxifylline and its metabolites during renal insufficiency.

Paap CM, Simpson KS, Horton MW, Schaefer KL, Lassman HB, Sack MR. Paap CM, et al. Among authors: horton mw. Ann Pharmacother. 1996 Jul-Aug;30(7-8):724-9. doi: 10.1177/106002809603000702. Ann Pharmacother. 1996. PMID: 8826548 Clinical Trial.

2

Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man.

Snoeck E, Van Peer A, Sack M, Horton M, Mannens G, Woestenborghs R, Meibach R, Heykants J. Snoeck E, et al. Psychopharmacology (Berl). 1995 Dec;122(3):223-9. doi: 10.1007/BF02246543. Psychopharmacology (Berl). 1995. PMID: 8748391 Clinical Trial.

3

Pharmacokinetics of oral and intravenous dolasetron mesylate in patients with renal impairment.

Dimmitt DC, Shah AK, Arumugham T, Cramer MB, Halstenson C, Horton M, Weir SJ. Dimmitt DC, et al. J Clin Pharmacol. 1998 Sep;38(9):798-806. J Clin Pharmacol. 1998. PMID: 9753207 Clinical Trial.

4

Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.

Garrelts JC, Godley PJ, Horton MW, Karboski JA. Garrelts JC, et al. Among authors: horton mw. Clin Pharm. 1987 Oct;6(10):795-9. Clin Pharm. 1987. PMID: 3505841

5

Estimation of theophylline clearance during continuous arteriovenous hemofiltration.

Horton MW, Godley PJ, Moore ES, Fineg J, Gillespie WR. Horton MW, et al. Artif Organs. 1990 Dec;14(6):416-20. doi: 10.1111/j.1525-1594.1990.tb02997.x. Artif Organs. 1990. PMID: 2281990

6

Renal dysfunction does not alter the pharmacokinetics or LDL-cholesterol reduction of atorvastatin.

Stern RH, Yang BB, Horton M, Moore S, Abel RB, Olson SC. Stern RH, et al. J Clin Pharmacol. 1997 Sep;37(9):816-9. doi: 10.1002/j.1552-4604.1997.tb05629.x. J Clin Pharmacol. 1997. PMID: 9549635

7

Advocating single-dose phenytoin loading.

Horton MW, Godley PJ. Horton MW, et al. Ann Emerg Med. 1988 Mar;17(3):295-6. doi: 10.1016/s0196-0644(88)80141-0. Ann Emerg Med. 1988. PMID: 3345027 No abstract available.

8

The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.

Aweeka F, Jayesekara D, Horton M, Swan S, Lambrecht L, Wilner KD, Sherwood J, Anziano RJ, Smolarek TA, Turncliff RZ. Aweeka F, et al. Br J Clin Pharmacol. 2000;49 Suppl 1(Suppl 1):27S-33S. doi: 10.1046/j.1365-2125.2000.00150.x. Br J Clin Pharmacol. 2000. PMID: 10771451 Free PMC article. Clinical Trial.

9

Continuous arteriovenous hemofiltration: an alternative to hemodialysis.

Horton MW, Godley PJ. Horton MW, et al. Am J Hosp Pharm. 1988 Jun;45(6):1361-8. Am J Hosp Pharm. 1988. PMID: 3046345 Review.

10

Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay.

Karboski JA, Godley PJ, Frohna PA, Horton MW, Reitmeyer WJ. Karboski JA, et al. Among authors: horton mw. Drug Intell Clin Pharm. 1988 Sep;22(9):703-5. doi: 10.1177/106002808802200913. Drug Intell Clin Pharm. 1988. PMID: 3063480

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters